Public Release: 

Men in recovery from Ebola should wear condoms for at least 3 months

SAGE

Los Angeles, CA (November 16, 2014) A new article reports that despite a clear lack of research on male survivors of Ebola, the current recommended practice of waiting at least three months after recovery to have unprotected sex should be upheld. This study was published today in Reproductive Sciences, a SAGE journal.

"Our exercise demonstrated that the current recommendations to prevent the sexual spread of Ebola are based on one mere observation," the researchers wrote. "Despite the evident need to conduct more research, for now, health care professionals should strongly recommend sexual abstinence or condom-protected encounters for at least three months."

Drs. Walter Cardona-Maya, Paula Velilla Hernandez, and Daniel Henao studied research from 1977 to 2007 on men in the convalescent phase of the Ebola virus (i.e. symptoms were fading and they were in recovery). They found only four studies that report male survivors of Ebola who donated convalescent semen. For these men, the virus persisted in their semen for an average of 66.6 days, and in one case, it persisted for 91 days.

The researchers continued, "The current Ebola Virus Disease outbreak is the longest and largest we have ever seen. Nonetheless, our results clearly demonstrate how much we ignore about it. Larger studies are needed to establish the social, clinical and biological determinants of this neglected disease. "

###

Find out more by reading the article, "Male Ebola Survivors: Do not forget to use a condom!" in Reproductive Sciences. For an embargoed copy of the full article, please email Camille.Gamboa@sagepub.com.

Reproductive Sciences (RS) is a peer-reviewed, monthly journal publishing original research and reviews in obstetrics and gynecology. RS is multi-disciplinary and includes research in basic reproductive biology and medicine, maternal-fetal medicine, obstetrics, gynecology, reproductive endocrinology, urogynecology, fertility/infertility, embryology, gynecologic/reproductive oncology, developmental biology, stem cell research, molecular/cellular biology and other related fields. http://rsx.sagepub.com/

SAGE is a leading international publisher of journals, books, and electronic media for academic, educational, and professional markets. Since 1965, SAGE has helped inform and educate a global community of scholars, practitioners, researchers, and students spanning a wide range of subject areas including business, humanities, social sciences, and science, technology, and medicine. An independent company, SAGE has principal offices in Los Angeles, London, New Delhi, Singapore and Washington DC. http://www.sagepublications.com

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.